1. The comparative safety of quinapril

   Newsletter Article 05 February 2013 Pages: 2 - 2

2. Anaesthetic antibody screening is problematic

   Newsletter Article 05 February 2013 Pages: 2 - 2

3. Maternal drug use linked to childhood cancer

   Newsletter Article 05 February 2013 Pages: 3 - 3

4. Is acetylcysteine overused in paracetamol overdose?

   Newsletter Article 05 February 2013 Pages: 3 - 3

5. Calcium antagonist-induced Parkinsonism

   Newsletter Article 05 February 2013 Pages: 3 - 3

6. Alprostadil

   Newsletter Article 05 February 2013 Pages: 4 - 4

7. Aluminium

   Newsletter Article 05 February 2013 Pages: 4 - 4

8. Ampicillin/hydralazine/hydrochlorothiazide

   Newsletter Article 05 February 2013 Pages: 4 - 4

9. Analgesics

   Newsletter Article 05 February 2013 Pages: 4 - 5

10. Antiparkinsonians withdrawal

    Newsletter Article 05 February 2013 Pages: 5 - 5

11. Atracurium besilate

    Newsletter Article 05 February 2013 Pages: 5 - 5

12. Bleomycin

    Newsletter Article 05 February 2013 Pages: 5 - 5

13. Buspirone

    Newsletter Article 05 February 2013 Pages: 5 - 5

14. Carbimazole

    Newsletter Article 05 February 2013 Pages: 5 - 5

15. Carboplatin

    Newsletter Article 05 February 2013 Pages: 5 - 5

16. Chloroquine abuse

    Newsletter Article 05 February 2013 Pages: 5 - 5

17. Cisplatin

    Newsletter Article 05 February 2013 Pages: 5 - 6

18. Contraceptives, oral

    Newsletter Article 05 February 2013 Pages: 6 - 6

19. Coumarin

    Newsletter Article 05 February 2013 Pages: 6 - 6

20. Cyclosporin

    Newsletter Article 05 February 2013 Pages: 6 - 6

21. Cyclosporin interaction

    Newsletter Article 05 February 2013 Pages: 6 - 6

22. Dexamethasone see Phenytoin

    Newsletter Article 05 February 2013 Pages: 6 - 6

23. Doxorubicin

    Newsletter Article 05 February 2013 Pages: 6 - 6

24. Etomidate

    Newsletter Article 05 February 2013 Pages: 6 - 7

25. Flumazenil

    Newsletter Article 05 February 2013 Pages: 7 - 7

26. Fluoxetine

    Newsletter Article 05 February 2013 Pages: 7 - 7

27. Gammaglobulin

    Newsletter Article 05 February 2013 Pages: 7 - 7

28. Hydralazine see Ampicillin/hydralazine/hydrochlorothiazide

    Newsletter Article 05 February 2013 Pages: 7 - 7

29. Hydroxychloroquine overdose

    Newsletter Article 05 February 2013 Pages: 7 - 7

30. Hydrochlorothiazide see Ampicillin/hydralazine/hydrochlorothiazide

    Newsletter Article 05 February 2013 Pages: 7 - 7

31. Interferon alpha 2B

    Newsletter Article 05 February 2013 Pages: 8 - 8

32. Iodine

    Newsletter Article 05 February 2013 Pages: 8 - 8

33. Ioxaglate sodium

    Newsletter Article 05 February 2013 Pages: 8 - 8

34. Ipecac

    Newsletter Article 05 February 2013 Pages: 8 - 8

35. Ivermectin

    Newsletter Article 05 February 2013 Pages: 8 - 8

36. Megestrol

    Newsletter Article 05 February 2013 Pages: 8 - 9

37. Nifedipine

    Newsletter Article 05 February 2013 Pages: 9 - 9

38. Pamidronic acid

    Newsletter Article 05 February 2013 Pages: 9 - 9

39. Pentamidine

    Newsletter Article 05 February 2013 Pages: 9 - 10

40. Phenobarbital/phenytoin

    Newsletter Article 05 February 2013 Pages: 10 - 10

41. Phenytoin

    Newsletter Article 05 February 2013 Pages: 10 - 10

42. Phenytoin see Phenobarbital/phenytoin

    Newsletter Article 05 February 2013 Pages: 10 - 10

43. Phytomenadione

    Newsletter Article 05 February 2013 Pages: 10 - 10

44. Pipemidic acid

    Newsletter Article 05 February 2013 Pages: 10 - 10

45. Povidone iodine

    Newsletter Article 05 February 2013 Pages: 10 - 11

46. Promethazine

    Newsletter Article 05 February 2013 Pages: 11 - 11

47. Sodium aurothiomalate

    Newsletter Article 05 February 2013 Pages: 11 - 11

48. Sulfadoxine

    Newsletter Article 05 February 2013 Pages: 11 - 11

49. Thiamazole

    Newsletter Article 05 February 2013 Pages: 11 - 11

50. Thyroxine

    Newsletter Article 05 February 2013 Pages: 11 - 11